我武生物 (300357.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

25.8x

EV/EBITDA

21.9x

Market Cap

CNY 12.18B

MomentumView details →

1D Return

−5.64%

YTD Return

−22.54%

RSI (14)

38.0

ValuationView details →

P/E (Fwd)

25.8x

EV/EBITDA

21.9x

Market Cap

CNY 12.18B

RSI (14)

38.0

MomentumView details →

1D Return

−5.64%

YTD Return

−22.54%

ProfitabilityView details →

Gross Margin

95.34%

Net Margin

39.18%

EBITDA Margin

45.10%

ROE (TTM)

15.55%

ROA (TTM)

14.50%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

+15.91%

EPS YoY

+35.20%

FCF YoY

+55.07%

Revenue CAGR 3Y

+5.84%

EPS CAGR 3Y

+2.99%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.16

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

26.14x

Quick Ratio

25.34x

Div Yield

0.68%

Div Rate

CNY 0.15

Div Growth 1Y

−31.82%

Financials snapshotView financials →

Revenue (TTM)

1.09B

Net Income (TTM)

425.83M

Op. CF (TTM)

392.36M

Next earningsOct 28, 2026 →

Latest newsMore news →

Wolwo Bio-Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders of 213 million yuan, up 20.59% year-on-year.9d ago

China's National Medical Products Administration approved Wolwo Bio-Pharmaceutical's clinical trial application for its cat dander membrane agent, a Class 1 therapeutic biological product, for allergic rhinitis related to cat dander sensitization.15d ago

Similar companies

恒帅股份300969.SZ 航天智装300455.SZ 光力科技300480.SZ 奥瑞金002701.SZ 美格智能002881.SZ 容大感光300576.SZ Find similar companies →

Latest newsMore news →

Wolwo Bio-Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders of 213 million yuan, up 20.59% year-on-year.9d ago China's National Medical Products Administration approved Wolwo Bio-Pharmaceutical's clinical trial application for its cat dander membrane agent, a Class 1 therapeutic biological product, for allergic rhinitis related to cat dander sensitization.15d ago